Upon assessing the recognition of circulating antibodies in the serum of T1D patients with native or modified GAD65, they found that T1D serum was highly reactive towards ROS modified GAD65 compared to the native unmodified antigen (P<0.001) (106). Here, GAD2 is linked to type 1 diabetes mellitus.